Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Ophthalmic Solution in Blepharitis
NCT00892970Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AzaSite in blepharitis, sponsored by Merck & Co.. Started Apr 2009; status: completed.
02
Drugs
AzaSite
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT00892970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892970.